CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiset tiedot
Päätekijä:	Eva, Israt Ara Jannat
Muut tekijät:	Rahman, Kazi Fatema
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2023
Aiheet:	CRISPR/Cas9 mechanism In vivo and in vitro modeling CRISPR/Cas9 delivery Mutation targeting in cancer and DMD Chromosomal rearrangement Mouse modeling Off-target limitation DMD mutation in human iPSCs Myoediting of DMD Therapeutic application of CRISPR Molecular genetics Cancer > Treatment
Linkit:	http://hdl.handle.net/10361/17764

Samankaltaisia teoksia

A review on CRISPR-Cas system based applications in Oncology
Tekijä: Sadia, Mir
Julkaistu: (2022)

CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
Tekijä: Maria, Amatul
Julkaistu: (2020)

Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
Tekijä: Nwabunwanne, Eze Uchenna
Julkaistu: (2022)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
Tekijä: Shaikat, Mahdi Mubin
Julkaistu: (2023)

CRISPR/Cas9 genome editing to treat sickle cell disease
Tekijä: Ullah, Mohammad
Julkaistu: (2023)

A review on CRISPR Technology as an Antiviral Tool
Tekijä: Srishti, Sanjida Ahmed
Julkaistu: (2023)

A review paper on Nanotechnology based strategies in the treatment of cancer
Tekijä: Rahman, Samia
Julkaistu: (2022)

Biased acquisition of spacers by the CRISPR System of the V. cholerae
Tekijä: Supan, Erena Tuzneen, et al.
Julkaistu: (2021)

Analysis and comparison between the Genome of CRISPR bacteriophages
Tekijä: Muntaha, Mumtasin
Julkaistu: (2021)

Distribution of complete CRISPR-Cas systems in vibrio cholerae and its effect on presence of plasmid derived contigs in complete genome assemblies
Tekijä: Reza, Ratul
Julkaistu: (2024)

Trend in approval of targeted biologics in the last two decades
Tekijä: Siddika, Khadiza
Julkaistu: (2024)

Exploring the possible function and acquisition pattern of self-targeting Spacers: in five common infectious bacteria
Tekijä: Kenneth, Mutebi John
Julkaistu: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Tekijä: Bristy, Israt Zerin
Julkaistu: (2021)

A comprehensive in silico investigation into the pathogenic SNPs in RTEL1 gene and their biological consequences
Tekijä: Tanshee, Rifah Rownak
Julkaistu: (2023)

The microbial models of molecular biology
Tekijä: Davis, Rowland H.

SIRT6 and cancer stem cells: is there any implication?
Tekijä: Sarker, Tanosi
Julkaistu: (2022)

Assessing the interspecies and intraspecies diversity of Cas1 and Cas3 proteins of the CRISPR-Cas system in vibrio cholera and Escherichia coli strains
Tekijä: Tabassum, Tahani, et al.
Julkaistu: (2022)

Genetic disorders associated with mutations in bHLH transcription factors: a review
Tekijä: Joya, Mollika Bharadwaj
Julkaistu: (2023)

Exploring of deletion mutation causative for Duchenne Muscular Dystrophy (DMD) in Bangladesh cohort
Tekijä: Eshaque, Tamannyat Binte
Julkaistu: (2024)

A review on targeted therapies for lung cancer
Tekijä: Ashraf, Anushey
Julkaistu: (2023)

Molecules associated with the development of lung cancer
Tekijä: Rahman, Adree, et al.
Julkaistu: (2023)

Inside the human genome
Tekijä: Avise, John C.

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Tekijä: Nahar, Kamrun
Julkaistu: (2023)

State of Thalassemia in Bangladesh: a review
Tekijä: Reedoy, Md. Shariqul Islam
Julkaistu: (2022)

Carcinogenesis

Molecular biology of cancer : mechanisms, targets, and therapeutics /
Tekijä: Pecorino, Lauren
Julkaistu: (2012)

Molecular biology of the gene /
Julkaistu: (2004)

Introduction to genetic analysis /
Julkaistu: (2012)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Tekijä: Meem, Manila
Julkaistu: (2023)

iGenetics : a molecular approach /
Tekijä: Russell, Peter J.
Julkaistu: (2006)

iGenetics : a molecular approach /
Tekijä: Russell, Peter J.
Julkaistu: (2010)

Modern genetic analysis : integrating genes and genomes /
Tekijä: Griffiths, Anthony J. F.
Julkaistu: (2002)

Targeted therapeutic options in the treatment of Breast Cancer
Tekijä: Alam, Kazi Tasnuva
Julkaistu: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Tekijä: Paul, Pulock
Julkaistu: (2024)

The current cancer situation in metropolitan Dhaka
Tekijä: Morshid, Golam
Julkaistu: (2023)

Molecular biology and biotechnology : a guide for teachers /
Tekijä: Kreuzer, Helen
Julkaistu: (2008)

Banking credit for farm inputs marketing business : macro perspective and micro realities / Bhupat M. Desai, N.V. Namboodiri.
Tekijä: Desai, B. M. 1938
Julkaistu: (1996)

Repurposing Albendazole and Mebendazole, an antiparasitic drug in treating colorectal cancer- a review
Tekijä: Mondal, Shawon
Julkaistu: (2023)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
Tekijä: Karim, Azrin
Julkaistu: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Tekijä: Tania, Umme
Julkaistu: (2023)